Human embryonic stem cells are a potentially viable treatment option for multiple sclerosis.
A team of researchers has discovered a novel neurotransmission that influences addiction-related memory.
Graduates with dual training in medicine and business increasingly pursue leadership roles and report greater career acceleration, according to a study published online June 20 in Academic Medicine.
Modifying the Course of Multiple Sclerosis: The Growing Treatment Armamentarium
The panelists hold a lively discussion on the values of using oral therapies over the more traditional options which are more commonly used.
Managing Chronic Pain: Practical Considerations to Improve Treatment Outcomes
The panelists discuss the risks and rewards of rotating opioid therapies for chronic pain patients.
A major advance has been made in creating a blood test to predict when at-risk people will develop Alzheimer's disease, according to scientists
For patients with manifest arterial disease, components of metabolic syndrome (MetS) correlate with smaller brain tissue volume, even in the absence of diabetes, according to a study published online June 19 in Diabetes Care.
Deficits in neurocognitive functioning are evident within days of a type 1 diabetes diagnosis in children and are associated with glycemic control over one year postdiagnosis, according to a study published online June 26 in Diabetes Care.
Use of 3,4-methylenedioxymethamphetamine, "Ecstasy," can trigger intracranial hemorrhage, subarachnoid hemorrhage (SAH), and possibly de novo aneurysm formation and rupture, according to a case report published online July 3 in BMJ Case Reports.
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for carotid artery stenosis in adults without a history of transient ischemic attack, stroke, or other neurological symptoms. These findings are presented in a final recommendation statement published online July 8 in the Annals of Internal Medicine.